Comparison of thrombogenicity in different types of drug‐eluting stents during transition from DAPT to SAPT

Documenti analoghi

• One‐month DAPT after biodegradable‐polymer everolimus‐eluting stent implantation in women at high‐bleeding risk: Insights from the POEM trial
  di: Matteo Maurina, et al.
  Pubblicazione: (2024)
• Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis
  di: Federico Giacobbe, et al.
  Pubblicazione: (2024)
• Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent
  di: Daphne van Vliet, et al.
  Pubblicazione: (2024)
• Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis
  di: Tobias Koch, et al.
  Pubblicazione: (2024)
• Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues
  di: Bernardo Cortese, et al.
  Pubblicazione: (2024)